The observations that tumor cells can acquire a senescent phenotype upon chemotherapeutic treatment (Chang et al., 1999; te Poele et al., 2002) prompted us to explore whether TRAIL-resistant cancer cells that are induced to undergo senescence and secrete SAS/SMS factors would confer TRAIL sensitivity to adjacent sister cells. The gene discussed is TNFSF10; the disease is cancer.